Vertex Pharmaceuticals (VRTX) — U.S. House trading disclosures
Health Care · NASDAQ
Vertex Pharmaceuticals (VRTX) has 12 reported U.S. House stock trading disclosures in our data, including 5 purchases and 7 sales among the most recent 12 (latest 2026-08-26).
Reported STOCK-Act stock transactions
| Trade date | Member | Type | Amount range | Filed | Source |
|---|---|---|---|---|---|
| 2026-08-26 | Hon. David J. Taylor | Sale | $1,001 – $15,000 | 2026-09-05 | PTR |
| 2026-01-29 | Hon. David J. Taylor | Sale | $1,001 – $15,000 | 2026-02-02 | PTR |
| 2025-08-07 | Hon. David J. Taylor | Purchase | $1,001 – $15,000 | 2025-09-02 | PTR |
| 2025-06-11 | Hon. Lisa McClain (spouse) | Sale | $1,001 – $15,000 | 2025-08-13 | PTR |
| 2025-06-10 | Hon. Lisa McClain (spouse) | Sale | $1,001 – $15,000 | 2025-08-13 | PTR |
| 2025-05-12 | Hon. Jefferson Shreve | Sale | $15,001 – $50,000 | 2025-06-22 | PTR |
| 2025-03-20 | Hon. Byron Donalds (spouse) | Sale | $1,001 – $15,000 | 2025-04-14 | PTR |
| 2025-03-20 | Hon. Byron Donalds | Sale | $1,001 – $15,000 | 2025-04-14 | PTR |
| 2025-03-13 | Hon. Jefferson Shreve | Purchase | $15,001 – $50,000 | 2025-04-11 | PTR |
| 2025-02-24 | Hon. Jefferson Shreve | Purchase | $15,001 – $50,000 | 2025-03-09 | PTR |
| 2024-12-11 | Hon. Lisa McClain (spouse) | Purchase | $1,001 – $15,000 | 2025-08-13 | PTR |
| 2024-10-23 | Hon. Julia Letlow | Purchase | $1,001 – $15,000 | 2026-01-13 | PTR |
Ask the chat about U.S. House trading in VRTX →
Source: U.S. House Clerk Periodic Transaction Reports (PTRs) filed under the STOCK Act. Disclosure can lag the actual trade by up to 45 days, so these are not real-time. Amounts are broad ranges as legally required — not exact figures. A transaction may belong to the member, their spouse, or a dependent child (see the owner column); a spouse or dependent trade is not the member's personal trade. This information is reused from the official public disclosure record for informational and public-interest (news) purposes only. Informational only — NOT financial advice, and NOT a signal to buy or sell.
See the full company profile: Vertex Pharmaceuticals (VRTX).
Last updated 2026-08-26 (most recent disclosed transaction date).
Our copy of the House Clerk archive runs through 2026-10-07 (the newest filing we have read). Because a member has up to 45 days to file, trades after 2026-08-23 may not be disclosed yet.
Informational only — NOT financial advice. These disclosures are sourced from the U.S. House Clerk public financial-disclosure archive and shown with their reported dates.